Clarithromycin is a macrolide antibiotic classified as a biopharmaceutical classification system (BCS) class II drug with low solubility, which results in limited bioavailability. This study aimed to enhance the solubility of clarithromycin by formulating it into a solid dispersion system using sodium alginate and chitosan as polymer matrices, with the addition of an alkalizer to modify the mic…